Evaluation partner for CYP Diabetes transition pilots

Descriptions

The appointment of Ipsos MORI to work as an evaluation partner to work with up to 21 pilot sites between September 2022-March 2025 to identify key scalable themes and learning to underpin improvements in diabetes transition and young adult care. They will co-develop a common minimum data set across all sites, linked to nationally available audit metrics; support continuous learning between, and across test sites assessing what worked well in terms of design and delivery, what could be improved. As well as assessing the impact of the pilot programme on key diabetes outcomes and health care costs. The evaluation will help ensure the development of sustainable service models to maximise improvements in outcomes for Children and young adults transitioning from paediatric care.